Circulating Tumor DNA Testing Supports Rapid Therapeutic Decision-Making in Metastatic Melanoma: A Case Report.

Behera, Tapas Ranjan; Song, Jung Min; Ko, Jennifer; Eicher, Donald; Arbesman, Joshua; Gastman, Brian; Farkas, Daniel H; Funchain, Pauline

Behera, Tapas Ranjan; Song, Jung Min; Ko, Jennifer; Eicher, Donald; Arbesman, Joshua; Gastman, Brian; Farkas, Daniel H; Funchain, Pauline.

Afiliação

Behera TR; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States.
Song JM; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States.
Ko J; Anatomic Pathology, Cleveland Clinic, Cleveland, OH, United States.
Eicher D; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States.
Arbesman J; Dermatology & Plastic Surgery Institute, Cleveland Clinic, Cleveland, OH, United States.
Gastman B; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States.
Farkas DH; Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, United States.
Funchain P; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States.

Front Oncol ; 12: 846187, 2022.

Article em En | MEDLINE | ID: mdl-35756682

Palavras-chave

BRAF mutation; Rapid ctDNA test; ctDNA; melanoma; rt-PCR; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google